Nassar Mahmoud, Nso Nso, Medina Luis, Ghernautan Victoria, Novikov Anastasia, El-Ijla Alli, Soliman Karim M, Kim Yungmin, Alfishawy Mostafa, Rizzo Vincent, Daoud Ahmed
Department of Medicine, Icahn School of Medicine at Mount Sinai / NYC Health + Hospitals / Queens, New York, NY 11432, United States.
Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, United States.
World J Hepatol. 2021 Sep 27;13(9):1058-1068. doi: 10.4254/wjh.v13.i9.1058.
The dying liver causes the suffocation of the kidneys, which is a simplified way of describing the pathophysiology of hepatorenal syndrome (HRS). HRS is characterized by reversible functional renal impairment due to reduced blood supply and glomerular filtration rate, secondary to increased vasodilators. Over the years, HRS has gained much attention and focus among hepatologists and nephrologists. HRS is a diagnosis of exclusion, and in some cases, it carries a poor prognosis. Different classifications have emerged to better understand, diagnose, and promptly treat this condition. This targeted review aims to provide substantial insight into the epidemiology, pathophysiology, diagnosis, and management of HRS, shed light on the various milestones of this condition, and add to our current understanding.
肝脏功能衰竭会导致肾脏功能障碍,这是对肝肾综合征(HRS)病理生理学的一种简化描述。HRS的特征是由于血管扩张剂增加导致血液供应减少和肾小球滤过率降低,进而引起可逆性肾功能损害。多年来,HRS在肝病学家和肾病学家中受到了广泛关注。HRS是一种排除性诊断,在某些情况下,预后较差。为了更好地理解、诊断和及时治疗这种疾病,出现了不同的分类方法。本靶向综述旨在深入探讨HRS的流行病学、病理生理学、诊断和管理,阐明该疾病的各个重要阶段,并增进我们目前的认识。